JPRN-UMIN000005583已完成2 期
Phase II Study of Carboplatin + Pemetrexed in chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer - Phase II Study of Carboplatin + Pemetrexed in chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Symptomatic Brain metastasis. 2.History of active double cancer. 3.Severe infection 4.Severe comorbidity (heart failure tendency to hemorrhages, uncontrollable hypertension, uncontrollable diabetes, etc) 5.Interstitial pneumonia or pulmonary fibrosis detectable on X ray. 6.With a history of drug sensitivity. 7.Pregnant or lactating women or those who declined contraception. 8.Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.
研究者
相似试验
已完成
2 期
Phase II study of carboplatin and pemetrexed plus bevacizumab after failure of first-line EGFR TKI therapy for non-small-cell lung cancer harboring EGFR mutation.on-squamous Non-small-cell Lung CancerJPRN-UMIN000004731Central Japan Lung Study Group27
进行中（未招募）
不适用
Phase II Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer - NDEUCTR2007-000913-13-ITELI LILLY47
进行中（未招募）
不适用
Phase 2 Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung CancerPatients with a histologic and/or cytologic diagnosis of LS-SCLC who are naïve to prior chemotherapy and/or thoracic radiotherapyMedDRA version: 9.1Level: LLTClassification code 10041069Term: Small cell lung cancer limited stageEUCTR2007-000913-13-GBEli Lilly and Company Limited55
进行中（未招募）
1 期
Phase 2 Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung CancerEstudio Fase II de terapia concurrente con Carboplatino, Pemetrexed y Radioterapia para Cáncer de Pulmón Microcítico en Estadio LimitadoEUCTR2007-000913-13-ESilly S.A.55
已完成
2 期
Phase II study of Pemetrexed and Carboplatin plus Bevacizumab for advanced non-small cell lung cancernon-squamous non-small-cell lung cancerJPRN-UMIN000003680ippon Medical School Hospital26